rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Glivec

Rediff.com  »  News  »   Glivec

  News for Glivec

  • Business

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court  judgement (pages 22 -26) quite extensively quoted from Sudip......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

'Novartis ruling won't affect pharma industry'

Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board, has recently ruled that the......

'US industry reviewing SC decision on Novartis'

The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......

The man behind Glivec hails verdict against Novartis

Even though Novartis and other multinational corporations are upset with the Indian Supreme Court’s decision to reject Novartis’ patent claim on Glivec, the key man behind the popular......
  Web results for Glivec
Will India's IP law and policy Modi-fy?

Yogesh Pai, Assistant Professor of Law at National Law University, Delhi, says that greater certainty and predictability in IP law and policy... ...

http://pharma.financialexpress.com/sections/management/4151-will-india-s-ip-law-and-policy-modi-fy
Edgard A Olaizola

Eli Lilly and Company, in the insulin segment, says there is a need for clarity in the policy framework as the pharmaceutical business is risky and... ...

http://www.smartinvestor.in/market/interviews-254117-interviewsdet-A_clear_policy_framework_must_Edgard_A_Olaizola.htm
Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook

Comments - LondonNo Novartis International AG / . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for... ...

http://andhranews.net/Business/2014/Novartis-maintained-strong-innovation-momentum-second-31575.htm
Novartis introduces new anti-malarial formulation, Coartem 80/480 in Kenya

Novartis has launched a new high quality antimalarial formulation of Coartem 80/480 (artemether/lumefantrine 80 mg/480 mg), for the treatment of... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=82848&sid=2
Novartis steps up innovation with key focus on oncology

S The key takeaway was that the company is looking at a unique approach of using single target for multiple indications, one drug that can treat... ...

http://www.moneycontrol.com/news/cnbc-tv18-comments/novartis-stepsinnovationkey-focusoncology_1114183.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z